Verrica Pharmaceuticals (VRCA) Asset Utilization Ratio (2021 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Asset Utilization Ratio of 0.87 for Q1 2026, up 287.83% year-over-year from 0.22 in Q1 2025, and up 7.02% quarter-over-quarter from 0.81 in Q4 2025.
Verrica Pharmaceuticals (VRCA) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.87 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 287.83% year-over-year to 0.87; the TTM figure through Mar 2026 stood at 0.87 (up 287.83% YoY), while the FY2025 annual figure was 0.7, up 530.26% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.87, up from 0.81 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.87 in Q1 2026, with the low at 0.01 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.19 (2022), against an average of 0.28.
- Peak annual rise in Asset Utilization Ratio reached 2582.76% in 2023, while the deepest fall reached 74.75% in 2023.
- Verrica Pharmaceuticals' Asset Utilization Ratio stood at 0.19 in 2022, then sank by 70.21% to 0.06 in 2023, then surged by 345.88% to 0.26 in 2024, then jumped by 216.2% to 0.81 in 2025, then grew by 7.02% to 0.87 in 2026.
- Business Quant data shows VRCA's Asset Utilization Ratio at 0.87 in Q1 2026, 0.81 in Q4 2025, and 0.77 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 0.13 |
| 10 | Verrica Pharmaceuticals | 100.03 Mn | 88.83 Mn | - | 0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.81 |
| Mar 31, 2026 | 0.87 |
| Dec 31, 2025 | 0.81 |
| Sep 30, 2025 | 0.77 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 0.24 |
| Mar 31, 2024 | 0.12 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.14 |